News

You dash into a convenience store for a quick snack, spot an apple and reach for a candy bar instead. Poor self-control may not be the only factor behind your choice, new research suggests. That's because our brains process taste information first, before factoring in health information, according to new research from Duke University.

Scientists have revealed that individuals infected by early variants of COVID-19 in 2020 produced sustained antibodies, however, these antibodies are not as effective against contemporary variants of the virus.

Data from nine cities in Mexico confirms that identifying dengue fever “hotspots” can provide a predictive map for future outbreaks of Zika and chikungunya. All three of these viral diseases are spread by the Aedes aegypti mosquito.

Researchers have shown how artificial intelligence methods can be used to find new pharmaceutical applications for natural products.

Researchers have developed a patch that plants can “wear” to monitor continuously for plant diseases or other stresses, such as crop damage or extreme heat.

MIT synthetic biologists have now developed an alternative approach to designing synthetic circuits, which relies exclusively on fast, reversible protein-protein interactions. This means that there's no waiting for genes to be transcribed or translated into proteins, so circuits can be turned on much faster, within seconds.

Researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention.

Researchers have developed a novel drug screening method that can test the effectiveness of therapeutic molecules designed to "glue" proteins together.

Scientists have shown that the shape of extracellular vesicles in body fluids could be a biomarker for identifying types of cancer.

In a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for early-stage Huntington’s disease, a neurodegenerative disorder that attacks brain cells.